Phaeohyphomycosis due to Exophiala xenobiotica as a cause of fungal arthritis in an HIV-infected patient

References

• Zalar P, Novak M, de Hoog GS, Gunde-Cimerman N. Dishwashers – a man-made ecological niche accommodating human opportunistic fungal pathogens. Fungal Biol 2011; 115: 997–1007.
   PubMed Web of Science ®Google Scholar
• Lian X, de Hoog GS. Indoor wet cells harbour melanized agents of cutaneous infection. Med Mycol 2010; 48: 622–628.
   PubMed Web of Science ®Google Scholar
• De Hoog GS, Guarro J, Gené J, Figueras MJ (eds). Atlas of Clinical Fungi, 2nd ed. Utrecht, The Netherlands and the Rovira I Virgili University, Reus, Spain: Centraalbureau voor Schimmelcultures, 2000
   Google Scholar
• Matos T, de Hoog GS, de Boer AG, de Crom I, Haase G. High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 2002; 45: 373–377.
   PubMed Web of Science ®Google Scholar
• Horre R, Schaal KP, Siekmeier R, . Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study. Respiration 2004; 71: 360–366.
   PubMed Web of Science ®Google Scholar
• Lebecque P, Leonard A, Huang D, . Exophiala (Wangiella) dermatitidis and cystic fibrosis – prevalence and risk factors. Med Mycol 2010; 48: S4–9.
   PubMed Web of Science ®Google Scholar
• Li DM, Li RY, de Hoog GS, Sudhadham M, Wang DL. Fatal Exophiala infections in China, with a report of seven cases. Mycoses 2011; 54: e136–142.
   PubMed Web of Science ®Google Scholar
• Badali H, Najafzadeh MJ, van Esbroeck M, . The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol; 2010; 48: 318–327.
   PubMed Web of Science ®Google Scholar
• Zeng JS, Sutton DA, Fothergill AW, . Spectrum of clinically relevant Exophiala species in the United States. J Clin Microbiol 2007; 45: 3713–3720.
   PubMed Web of Science ®Google Scholar
• Badali H, Hedayati MT, Bahoosh M, . Exophiala oligosperma involved in a refractory chronic rhinosinusitis. Eur Rev Med Pharmacol Sci 2011; 15: 319–323.
   PubMed Web of Science ®Google Scholar
• Tokuhisa Y, Hagiya Y, Hiruma M, Nishimura K. Phaeohyphomycosis of the face caused by Exophiala oligosperma. Mycoses 2011; 54: e240–243.
   Web of Science ®Google Scholar
• Aoyama Y, Nomura M, Yamanaka S, Ogawa Y, Kitajima Y. Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient. Med Mycol 2009; 47: 95–99.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Arendrup MC, Barchiesi F, . EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398–405.
   PubMed Web of Science ®Google Scholar
• De Hoog GS, Zeng JS, Harrak MJ, Sutton DA. Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons. Antonie Van Leeuwenhoek 2006; 90: 257–268.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zeng J, de Hoog GS, Attili-Angelis D, Prenafeta-Boldu FX. Isolation and identification of black yeasts by enrichment on atmospheres of monoaromatic hydrocarbons. Microb Ecol 2010; 60: 149–156.
   PubMed Web of Science ®Google Scholar
• Seyedmousavi S, Badali H, Chlebicki A, . Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic. Fungal Biol 2011; 115: 1030–103.
   PubMed Web of Science ®Google Scholar
• Legris T, Massad M, Purgus R, . Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient. Transpl Infect Dis; 2011; 13: 303–308.
   PubMed Web of Science ®Google Scholar
• Breton G, Adle-Biassette H, Therby A, . Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006; 20: 119–121.
   PubMed Web of Science ®Google Scholar
• Nachman S, Alpan O, Malowitz R, Spitzer ED. Catheter-associated fungemia due to Wangiella (Exophiala) dermatitidis. J Clin Microbiol 1996; 34: 1011–1013.
   PubMed Web of Science ®Google Scholar
• Hiruma M, Kawada A, Ohata H, . Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses 1993; 36: 1–7.
   PubMed Web of Science ®Google Scholar
• Calvo E, Pastor FJ, Guarro J. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species. J Antimicrob Chemother 2010; 65: 1455–1459.
   PubMed Web of Science ®Google Scholar
• Zeng JS, De Hoog GS. Exophiala spinifera and its allies: diagnostics from morphology to DNA barcoding. Med Mycol 2008; 46: 193–208.
   PubMed Web of Science ®Google Scholar
• Negroni R, Helou SH, Petri N, . Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin Infect Dis 2004; 38: e15–20.
   Web of Science ®Google Scholar
• Al-Tawfiq JA, Amr SS. Madura leg due to Exophiala jeanselmei successfully treated with surgery and itraconazole therapy. Med Mycol 2009; 47: 648–652.
   PubMed Web of Science ®Google Scholar
• Vitale RG, de Hoog GS. Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade. Med Mycol 2002; 40: 545–556.
   PubMed Web of Science ®Google Scholar
• Harris JE, Sutton DA, Rubin A, . Exophiala spinifera as a cause of cutaneous phaeohyphomycosis: case study and review of the literature. Med Mycol 2009; 47: 87–93.
   PubMed Web of Science ®Google Scholar
• Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol 2009; 47: 41–43.
   PubMed Web of Science ®Google Scholar